Overstretching the mutant prevention concentration (multiple letters) [2]

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 4, 2003, Pages 732-733

  Livermore, David M ^c   Smith, Heather J ^a,b   Hoban, Daryl J ^a,b   Zhanel, George G ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Mutation; Resistance; Selection pressure

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL FLORA; CITROBACTER; CLINICAL PRACTICE; CONCENTRATION RESPONSE; DNA TRANSFER; DRUG TARGETING; DRUG USE; ENTEROBACTER; GENE MUTATION; HUMAN; LETTER; NONHUMAN; PHARMACODYNAMICS; PREVENTION; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; SERRATIA; SPECIES DIFFERENCE; TREATMENT PLANNING;

DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION;

EID: 0141928520     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg377     Document Type: Letter

References (0)